Amended agenda of the Annual General Meeting of Medicalgorithmics S.A. convened for 26 June 2018
Current Report No 12/2018
Date: 06.06.2018
Legal basis: Article 56(1)(2) of the Act on Public Offering – current and periodical information
The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (“Company”) announces that on 5 June 2018 the Company received from Towarzystwo Funduszy Inwestycyjnych PZU S.A. with its registered office in Warsaw, acting on behalf of the following investment funds managed by it:
PZU IMPULS SFIO SUBFUNDUSZ PZU IMPULS AKCJI POLSKICH
PZU SFIO UNIVERSUM
PZU FIO PARASOLOWY SUBFUNDUSZ PZU AKCJI KRAKOWIAK
PZU FIO PARASOLOWY SUBFUNDUSZ PZU STABILNEGO WZROSTU MAZUREK
PZU FIO PARASOLOWY SUBFUNDUSZ PZU ZROWNOWAZONY
PZU FIO PARASOLOWY SUBFUNDUSZ PZU AKCJI MALYCH I SREDNICH SPOŁEK
PZU SFIO GLOBALNYCH INWESTYCJI SUBFUNDUSZ AKCJI SPOŁEK DYWIDENDOWYCH
PZU FIO PARASOLOWY SUBFUNDUSZ PZU ENERGIA MEDYCYNA EKOLOGIA
PZU FIZ MEDYCZNY
(collectively: the “Funds”) which represent at least 1/20 of the Company’s share capital – a request based on Article 401 Clause 1 of the Code of Commercial Companies to place the following items: “Determination of the number of Members of the Company’s Supervisory Board” and “Changes in the Company’s Supervisory Board” on the agenda of the Company’s Annual General Meeting convened for 26 June 2018 (“Annual Meeting”), along with a justification and draft resolutions. Acting pursuant to Article 401 Clause 2 of the Code of Commercial Companies, the Management Board of the Company announces amendments to the agenda of the General Meeting introduced at the request of the Funds, which consist in placing the following items on the agenda:
- Determination of the number of Members of the Company’s Supervisory Board.
- Changes to the Company’s Supervisory Board.
As a result of introducing these items, the numbering of the previous item 15 is changed to 17. As a consequence of the foregoing, the Management Board announces a new agenda of the General Meeting:
Opening of the General Meeting;
Election of the Chairman of the General Meeting;
Determining that the General Meeting has been duly convened and is capable of adopting binding resolutions;
Adoption of the agenda of the General Meeting;
Review of the financial statements of Medicalgorithmics S.A. for 2017, the Medicalgorithmics S.A. Directors’ Report for 2017, the consolidated financial statements of the Medicalgorithmics Group for 2017, the Medicalgorithmics Group Directors’ Report for 2017 and the Management Board’s recommendation regarding the disbursement of dividend and coverage of loss for 2017;
Review of the Medicalgorithmics S.A. Supervisory Board’s Report for 2017 together with the report on the results of evaluation of the financial statements of Medicalgorithmics S.A. for 2017, the Medicalgorithmics S.A. Directors’ Report for 2017, the consolidated financial statements of the Medicalgorithmics Group for 2017, the Medicalgorithmics Group Directors’ Report for 2017 as well as review of the Medicalgorithmics S.A. Supervisory Board’s resolution on its opinion concerning the Management Board’s recommendation regarding the disbursement of dividend and coverage of loss for 2017;
Adoption of a resolution on approving the financial statements of Medicalgorithmics S.A. for 2017;
Adoption of a resolution on approving the Medicalgorithmics S.A. Director’s Report for 2017;
Adoption of a resolution on approving the consolidated financial statements of the Medicalgorithmics Group for 2017;
Adoption of a resolution on approving the Medicalgorithmics Group Director’s Report for 2017;
Adoption of resolutions on granting discharge to particular Members of the Management Board of Medicalgorithmics S.A. for 2017;
Adoption of resolutions on granting discharge to particular Members of the Supervisory Board of Medicalgorithmics S.A. for 2017;
Adoption of a resolution on the coverage of loss for 2017;
Adoption of a resolution on allocating the profit from previous years accumulated within the supplementary capital of Medicalgorithmics S.A. for the payment of dividend for the Company’s Shareholders;
Determination of the number of Members of the Company’s Supervisory Board;
Changes to the Company’s Supervisory Board;
Closing the General Meeting.
The Management Board of the Company submits, as an attachment, the request from the Funds together with the justification and draft resolutions. Detailed legal basis: Clause 19(1)(3) of the Regulation of the Minister of Finance dated 29 March 2018 on current and periodic information to be published by issuers of securities and conditions for recognition as equivalent of information whose disclosure is required under the laws of a non-member state (Journal of Laws of 2018, item 757)